Hematology-Oncology Therapy 2e
Wysyłka: Niedostępna
Sugerowana cena detaliczna 352,00 PLN
Nasza cena: 329,12 PLN
Oszczędzasz 6%
Dodaj do Schowka
Zaloguj się
Przypomnij hasło
×
×
Oferujemy szeroki asortyment - ponad 120 tys. produktów
Dysponujemy solidną wiedzą - działamy już 11 lat
Dbamy o wybór najcenniejszych tytułów
Opis: Hematology-Oncology Therapy 2e - Michael Boyiadzis, Peter Lebowitz, James Frame

The first clinical manual to bridge the disciplines of hematology and oncology 500 treatment regimens in a quick-scan presentation! Hematology-Oncology Therapy is a readily-accessible, up-to-date therapy guide for oncologic and non-neoplastic hematologic disorders. This comprehensive book presents 500 treatment regimens in a concise, uniform format and integrates critical treatment information from the oncology and hematology literature, practice guidelines, and the experience of experts. The new edition is thoroughly updated with new content, drug regimens, and authors. Features Completely updated to reflect new classes of cancer drugs, including targeted biologicals NEW 9 additional international contributors NEW chapters: Pregnancy and Chemotherapy; Hematologic Complications of Pregnancy; Hemochromatosis NEW "Expert Opinion" added to every Oncology chapter NEW Drug Index More comprehensive than any other manual on the market Thoroughly updated content:Section I: Oncology;Section II: Supportive Care, Drug Preparation, Complications, and Screening;Section III: Selected Hematologic Diseases. "This is a high quality book that provides a comprehensive overview of a large number of tumor types as well as issues in benign hematology. The quality is high, the information is concise, and the readability is better than that of many other guides in the field."--Doody's Review Service Doody's 20070202 "The authors have accomplished their goal of producing a readily available hematology and oncology reference for office-and hospital-based clinicians. Clinicians of all disciplines involved in the treatment of patients with hematology and oncology disorders would benefit from the addition of Hematology-Oncology Therapy to their library. It would also be beneficial to pharmacies specializing in chemotherapy preparation in both community clinics and hospitals. Students and postgraduate residents and fellows would also benefit from this reference book."--The Annals of Pharmacotherapy The Annals of Pharmacotherapy 20070201Authors Preface SECTION I: ONCOLOGY 1. Adrenocortical Cancer, Peter F. Lebowitz and Tito Fojo 2. Anal Cancer, David Ryan and Robert Mayer 3. Biliary Tract Cancer: Gallbladder Cancer and Cholangiocarcinoma, Verena Sagaster and Werner Scheithauer 4. Bladder Cancer, Edwin M. Posadas and William L. Dabut 5. Brain Cancer, Lyndon Kim and Howard Fine 6. Breast Cancer, Peter F. Lebowitz and Jo Anne Zujewski 7. Carcinoid Tumors, Eva Tiensuu Janson and Kjell Oberg 8. Carcinoma of Unknown Primary, David Spigel and F. Anthony Greco 9. Cervical Cancer, Deirdre O'Mahony and Peter Rose 10. Colorectal Cancer, Gregory Leonard and Jean Grem 11. Endometrial Cancer, Deirdre O'Mahoney and Franco Muggia 12. Esophageal Cancer, Gauri Varadhachary and Jaffer Ajani 13. Gastric Cancer, Manish A. Shah, Dana Rathkopf, and Gary K. Schwartz 14. Gestational Trophoblastic Neoplasia, Michael M. Boyiadzis and John Lurain 15. Head and Neck Cancers, Erin Donovan and Barbara Conley 16. Hepatocellular Carcinoma, Joan Maurel and Jordi Bruix 17. HIV-Related Malignancies, Pallavi Kumar and Richard F. Little 18. Leukemia, Acute Lymphoblastic (Adult), Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp 19. Leukemia, Acute Myelogenous, Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp 20. Leukemia, Chronic Lymphocytic, Salah Abbasi and Bruce D. Cheson 21. Leukemia, Chronic Myelogenous, Michael W.N. Deininger and Brian J. Druker 22. Leukemia, Hairy Cell, Martin S. Tallman 23. Lung Cancer, Enriqueta Felip and Rafael Rosell 24. Lymphoma, Hodgkin, Christina M. Annunziata and Dan L. Longo 25. Lymphoma, Non-Hodgkin, Kieron Dunleavy, David R. Kohler, and Wyndham H. Wilson 26. Melanoma, Michael M. Boyiadzis and Barry Gause 27. Mesothelioma, Verna Vanderpuye and Nicholas J. Vogelzang 28. Multiple Myeloma, Robert Dean and Cynthia E. Dunbar 29. Ovarian Cancer, Eddie Reed 30. Pancreatic Cancer, Michael M. Boyiadzis and Daniel D. Von Hoff 31. Pheochromocytoma, Michael M. Boyiadzis, Karel Pacak, and Tito Fojo 32. Prostate Cancer, Peter F. Lebowitz and William L. Dabut 33. Renal Cell Carcinoma, Michael M. Boyiadzis and Susan Bates 34. Sarcomas, Janice Walshe, Tito Fojo, and Lee Helman 35. Testicular Cancer, Michael M. Boyiadzis and Scott Saxman 36. Thymic Carcinoma, Hanneke Wilmink and Guisseppe Giaconne 37. Thyroid Cancer, Kenneth B. Ain 38. Vaginal Cancer, Thomas Chen and Franco Muggia SECTION II: SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING 39. Chemotherapy-Induced Nausea and Vomiting: Prophylaxis and Treatment, Thomas E. Hughes 40. Drug Preparation and Administration, David R. Kohler 41. Chemotherapy Dose Modifications, Michael Menefee, Pamela W. McDevitt, and Tito Fojo 42. Antineoplastic Drugs: Preventing and Managing Extravasation, David R. Kohler 43. Indications for Growth Factors in the Hemotology-Oncology Setting, Pamela W. McDevitt and James N. Frame 44. Indications for Bisphosphonates in the Hematology-Oncology Setting, Reem A. Shalabi, David R. Kohler, and James N. Frame 45. Transfusion Therapy, Ashok Nambiar and Susan Leitman 46. Oncologic Emergencies, Michael M. Boyiadzis and Tito Fojo 47. Fever and Neutropenia, Juan Gea-Banacloche and Thomas J. Walsh 48. Catheter-Related Bloodstream Infections: Managing and Prevention, Naomi P. O'Grady 49. Venous Catheter-Related Thrombosis, McDonald Horne 50. Complications and Follow-up After Hematopoietic Stem Cell Transplantation (HSCT), Michael M. Boyiadzis, Juan Gea-Banacloche, and Michael R. Bishop 51. Radiation Complications, Diana Stripp and Eli Glatstein 52. Cancer Pain: Assessment and Management, Ann Berger 53. Hospice Care and End-of-Life Issues, Charles F. Von Gunten and David Weismann 54. Cancer Screening, Jennifer Eng-Wong, Kathleen Calzone, and Sheila A. Prindiville 55. Genetics of Common Inherited Cancer Syndromes, Kathleen Calzone, Jennifer Eng-Wong, and Sheila A. Prindiville SECTION III: SELECTED HEMATOLOGIC DISEASES 56. von Willebrand Disease, Michael M. Boyiadzis and Margaret E. Rick 57. Hemophilia, Steven J. Jubelirer 58. The Hypercoagulable State, Jeffrey I. Zwicker and Kenneth A. Bauer 59. Heparin-Induced Thrombocytopenia (HIT) and HIT with Thromboembolic Syndrome (HITTS), McDonald K. Horne, III 60. Autoimmune Hemolytic Anemia, James N. Frame 61. Sickle Cell Disease: Acute Complications, James N. Frame, Steven J. Jubelirer, and Griffin P. Rodgers 62. Aplastic Anemia, Michael M. Boyiadzis and Neal S. Young 63. Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS), Kiarash Kojouri and James N. George 64. Idiopathic Thrombocytopenic Purpura, Kiarash Kojouri and James N. George 65. Polycythemia Vera, Celia L. Grosskreutz and Steven Fruchtman 66. Essential Thrombocythemia, Celia L. Grosskreutz and Steven Fruchtman 67. Myelodysplastic Syndromes, Michael M. Boyiadzis and Neal S. Young


Szczegóły: Hematology-Oncology Therapy 2e - Michael Boyiadzis, Peter Lebowitz, James Frame

Tytuł: Hematology-Oncology Therapy 2e
Autor: Michael Boyiadzis, Peter Lebowitz, James Frame
Producent: McGraw-Hill
ISBN: 9780071637893
Rok produkcji: 2000
Ilość stron: 1904
Oprawa: Miękka
Waga: 3.59 kg


Recenzje: Hematology-Oncology Therapy 2e - Michael Boyiadzis, Peter Lebowitz, James Frame
Zaloguj się
Przypomnij hasło
×
×

Hematology-Oncology Therapy 2e

, ,

The first clinical manual to bridge the disciplines of hematology and oncology 500 treatment regimens in a quick-scan presentation! Hematology-Oncology Therapy is a readily-accessible, up-to-date therapy guide for oncologic and non-neoplastic hematologic disorders. This comprehensive book presents 500 treatment regimens in a concise, uniform format and integrates critical treatment information from the oncology and hematology literature, practice guidelines, and the experience of experts. The new edition is thoroughly updated with new content, drug regimens, and authors. Features Completely updated to reflect new classes of cancer drugs, including targeted biologicals NEW 9 additional international contributors NEW chapters: Pregnancy and Chemotherapy; Hematologic Complications of Pregnancy; Hemochromatosis NEW "Expert Opinion" added to every Oncology chapter NEW Drug Index More comprehensive than any other manual on the market Thoroughly updated content:Section I: Oncology;Section II: Supportive Care, Drug Preparation, Complications, and Screening;Section III: Selected Hematologic Diseases. "This is a high quality book that provides a comprehensive overview of a large number of tumor types as well as issues in benign hematology. The quality is high, the information is concise, and the readability is better than that of many other guides in the field."--Doody's Review Service Doody's 20070202 "The authors have accomplished their goal of producing a readily available hematology and oncology reference for office-and hospital-based clinicians. Clinicians of all disciplines involved in the treatment of patients with hematology and oncology disorders would benefit from the addition of Hematology-Oncology Therapy to their library. It would also be beneficial to pharmacies specializing in chemotherapy preparation in both community clinics and hospitals. Students and postgraduate residents and fellows would also benefit from this reference book."--The Annals of Pharmacotherapy The Annals of Pharmacotherapy 20070201Authors Preface SECTION I: ONCOLOGY 1. Adrenocortical Cancer, Peter F. Lebowitz and Tito Fojo 2. Anal Cancer, David Ryan and Robert Mayer 3. Biliary Tract Cancer: Gallbladder Cancer and Cholangiocarcinoma, Verena Sagaster and Werner Scheithauer 4. Bladder Cancer, Edwin M. Posadas and William L. Dabut 5. Brain Cancer, Lyndon Kim and Howard Fine 6. Breast Cancer, Peter F. Lebowitz and Jo Anne Zujewski 7. Carcinoid Tumors, Eva Tiensuu Janson and Kjell Oberg 8. Carcinoma of Unknown Primary, David Spigel and F. Anthony Greco 9. Cervical Cancer, Deirdre O'Mahony and Peter Rose 10. Colorectal Cancer, Gregory Leonard and Jean Grem 11. Endometrial Cancer, Deirdre O'Mahoney and Franco Muggia 12. Esophageal Cancer, Gauri Varadhachary and Jaffer Ajani 13. Gastric Cancer, Manish A. Shah, Dana Rathkopf, and Gary K. Schwartz 14. Gestational Trophoblastic Neoplasia, Michael M. Boyiadzis and John Lurain 15. Head and Neck Cancers, Erin Donovan and Barbara Conley 16. Hepatocellular Carcinoma, Joan Maurel and Jordi Bruix 17. HIV-Related Malignancies, Pallavi Kumar and Richard F. Little 18. Leukemia, Acute Lymphoblastic (Adult), Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp 19. Leukemia, Acute Myelogenous, Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp 20. Leukemia, Chronic Lymphocytic, Salah Abbasi and Bruce D. Cheson 21. Leukemia, Chronic Myelogenous, Michael W.N. Deininger and Brian J. Druker 22. Leukemia, Hairy Cell, Martin S. Tallman 23. Lung Cancer, Enriqueta Felip and Rafael Rosell 24. Lymphoma, Hodgkin, Christina M. Annunziata and Dan L. Longo 25. Lymphoma, Non-Hodgkin, Kieron Dunleavy, David R. Kohler, and Wyndham H. Wilson 26. Melanoma, Michael M. Boyiadzis and Barry Gause 27. Mesothelioma, Verna Vanderpuye and Nicholas J. Vogelzang 28. Multiple Myeloma, Robert Dean and Cynthia E. Dunbar 29. Ovarian Cancer, Eddie Reed 30. Pancreatic Cancer, Michael M. Boyiadzis and Daniel D. Von Hoff 31. Pheochromocytoma, Michael M. Boyiadzis, Karel Pacak, and Tito Fojo 32. Prostate Cancer, Peter F. Lebowitz and William L. Dabut 33. Renal Cell Carcinoma, Michael M. Boyiadzis and Susan Bates 34. Sarcomas, Janice Walshe, Tito Fojo, and Lee Helman 35. Testicular Cancer, Michael M. Boyiadzis and Scott Saxman 36. Thymic Carcinoma, Hanneke Wilmink and Guisseppe Giaconne 37. Thyroid Cancer, Kenneth B. Ain 38. Vaginal Cancer, Thomas Chen and Franco Muggia SECTION II: SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING 39. Chemotherapy-Induced Nausea and Vomiting: Prophylaxis and Treatment, Thomas E. Hughes 40. Drug Preparation and Administration, David R. Kohler 41. Chemotherapy Dose Modifications, Michael Menefee, Pamela W. McDevitt, and Tito Fojo 42. Antineoplastic Drugs: Preventing and Managing Extravasation, David R. Kohler 43. Indications for Growth Factors in the Hemotology-Oncology Setting, Pamela W. McDevitt and James N. Frame 44. Indications for Bisphosphonates in the Hematology-Oncology Setting, Reem A. Shalabi, David R. Kohler, and James N. Frame 45. Transfusion Therapy, Ashok Nambiar and Susan Leitman 46. Oncologic Emergencies, Michael M. Boyiadzis and Tito Fojo 47. Fever and Neutropenia, Juan Gea-Banacloche and Thomas J. Walsh 48. Catheter-Related Bloodstream Infections: Managing and Prevention, Naomi P. O'Grady 49. Venous Catheter-Related Thrombosis, McDonald Horne 50. Complications and Follow-up After Hematopoietic Stem Cell Transplantation (HSCT), Michael M. Boyiadzis, Juan Gea-Banacloche, and Michael R. Bishop 51. Radiation Complications, Diana Stripp and Eli Glatstein 52. Cancer Pain: Assessment and Management, Ann Berger 53. Hospice Care and End-of-Life Issues, Charles F. Von Gunten and David Weismann 54. Cancer Screening, Jennifer Eng-Wong, Kathleen Calzone, and Sheila A. Prindiville 55. Genetics of Common Inherited Cancer Syndromes, Kathleen Calzone, Jennifer Eng-Wong, and Sheila A. Prindiville SECTION III: SELECTED HEMATOLOGIC DISEASES 56. von Willebrand Disease, Michael M. Boyiadzis and Margaret E. Rick 57. Hemophilia, Steven J. Jubelirer 58. The Hypercoagulable State, Jeffrey I. Zwicker and Kenneth A. Bauer 59. Heparin-Induced Thrombocytopenia (HIT) and HIT with Thromboembolic Syndrome (HITTS), McDonald K. Horne, III 60. Autoimmune Hemolytic Anemia, James N. Frame 61. Sickle Cell Disease: Acute Complications, James N. Frame, Steven J. Jubelirer, and Griffin P. Rodgers 62. Aplastic Anemia, Michael M. Boyiadzis and Neal S. Young 63. Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS), Kiarash Kojouri and James N. George 64. Idiopathic Thrombocytopenic Purpura, Kiarash Kojouri and James N. George 65. Polycythemia Vera, Celia L. Grosskreutz and Steven Fruchtman 66. Essential Thrombocythemia, Celia L. Grosskreutz and Steven Fruchtman 67. Myelodysplastic Syndromes, Michael M. Boyiadzis and Neal S. Young

Powiadom o dostępności
Podaj swój e-mail a zostaniesz poinformowany jak tylko pozycja będzie dostępna.
×
Cena 352,00 PLN
Nasza cena 329,12 PLN
Oszczędzasz 6%
Wysyłka: Niedostępna
Dodaj do Schowka
Zaloguj się
Przypomnij hasło
×
×

Szczegóły: Hematology-Oncology Therapy 2e - Michael Boyiadzis, Peter Lebowitz, James Frame

Tytuł: Hematology-Oncology Therapy 2e
Autor: Michael Boyiadzis, Peter Lebowitz, James Frame
Producent: McGraw-Hill
ISBN: 9780071637893
Rok produkcji: 2000
Ilość stron: 1904
Oprawa: Miękka
Waga: 3.59 kg


Recenzje: Hematology-Oncology Therapy 2e - Michael Boyiadzis, Peter Lebowitz, James Frame

Zaloguj się
Przypomnij hasło
×
×

Klienci, którzy kupili oglądany produkt kupili także:


Zaloguj się
Przypomnij hasło
×
×
Dodane do koszyka
×